220 related articles for article (PubMed ID: 33504885)
1. Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control.
Müller J; Kreutz C; Ringhof S; Koeppel M; Kleindienst N; Sam G; Schneeweiss A; Wiskemann J; Weiler M
Sci Rep; 2021 Jan; 11(1):2398. PubMed ID: 33504885
[TBL] [Abstract][Full Text] [Related]
2. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
[TBL] [Abstract][Full Text] [Related]
3. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.
Wang M; Cheng HL; Lopez V; Sundar R; Yorke J; Molassiotis A
BMC Cancer; 2019 Nov; 19(1):1151. PubMed ID: 31775665
[TBL] [Abstract][Full Text] [Related]
4. Out of balance - Postural control in cancer patients before and after neurotoxic chemotherapy.
Müller J; Ringhof S; Vollmer M; Jäger LB; Stein T; Weiler M; Wiskemann J
Gait Posture; 2020 Mar; 77():156-163. PubMed ID: 32036320
[TBL] [Abstract][Full Text] [Related]
5. Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments.
McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Menant J; Friedlander M; Lewis CR; Hertzberg M; O'Neill S; King T; Bosco A; Harrison M; Park SB
J Natl Compr Canc Netw; 2019 Aug; 17(8):949-955. PubMed ID: 31390588
[TBL] [Abstract][Full Text] [Related]
6. Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study.
Monfort SM; Pan X; Loprinzi CL; Lustberg MB; Chaudhari AMW
Integr Cancer Ther; 2019; 18():1534735419828823. PubMed ID: 30741022
[TBL] [Abstract][Full Text] [Related]
7. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Lin KY; Chen PS; Lin CF
BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
Cheng HL; Molassiotis A
Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device.
Matsuoka A; Mitsuma A; Maeda O; Kajiyama H; Kiyoi H; Kodera Y; Nagino M; Goto H; Ando Y
Cancer Sci; 2016 Oct; 107(10):1453-1457. PubMed ID: 27412083
[TBL] [Abstract][Full Text] [Related]
10. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population.
Mols F; van de Poll-Franse LV; Vreugdenhil G; Beijers AJ; Kieffer JM; Aaronson NK; Husson O
Eur J Cancer; 2016 Dec; 69():28-38. PubMed ID: 27814471
[TBL] [Abstract][Full Text] [Related]
11. Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction.
Sharma S; Venkitaraman R; Vas PR; Rayman G
Brain Behav; 2015 Jul; 5(7):e00354. PubMed ID: 26221574
[TBL] [Abstract][Full Text] [Related]
12. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
[TBL] [Abstract][Full Text] [Related]
13. Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.
Yeo F; Ng CC; Loh KWJ; Molassiotis A; Cheng HL; Au JSK; Leung KT; Li YC; Wong KH; Suen L; Chan CW; Yorke J; Farrell C; Bandla A; Ang E; Lopez V; Sundar R; Chan A
Support Care Cancer; 2019 Dec; 27(12):4753-4762. PubMed ID: 30972646
[TBL] [Abstract][Full Text] [Related]
14. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
15. Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial.
Schwenk M; Grewal GS; Holloway D; Muchna A; Garland L; Najafi B
Gerontology; 2016; 62(5):553-63. PubMed ID: 26678611
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice.
Vasquez S; Guidon M; McHugh E; Lennon O; Grogan L; Breathnach OS
Ir J Med Sci; 2014 Mar; 183(1):53-8. PubMed ID: 23832573
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
[TBL] [Abstract][Full Text] [Related]
18. A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention.
Kneis S; Wehrle A; Dalin D; Wiesmeier IK; Lambeck J; Gollhofer A; Bertz H; Maurer C
BMC Neurol; 2020 Jan; 20(1):23. PubMed ID: 31948403
[TBL] [Abstract][Full Text] [Related]
19. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB
J Natl Compr Canc Netw; 2023 Feb; 21(2):125-132.e3. PubMed ID: 36791763
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
